Latest filing published 16 May 2011 for Celera CORP, €1.8M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Quest Diagnostics Inc discloses dealings in 2 companies, chiefly Celera Corp and Aspira Women's Health Inc. Between 24 August 2007 and 12 May 2011, the trades on record add up to 8 filings.
The open-market record is one-sided, with 7 purchases worth €42.1M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant. So far in 2011, the count stands at 7 purchases and no sales.
The median purchase comes to €4.3M.
The record was last updated on 16 May 2011 with an open-market purchase (€1.8M) in Celera Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations